Kezar Life Sciences
Price & Volume
Stats
See more52W Range | $3.62-$9.18 |
Market Cap | $27.8M |
Shares Short | 799,726 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$54M |
Diluted EPS | -$9.70 |
News
See moreYahoo Finance • 2 months ago
Highlights – June Quarter 2025
Yahoo Finance • 2 months ago
Kezar Life Sciences stock gains after FDA lifts partial clinical hold
Yahoo Finance • 2 years ago
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 3 years ago
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
About
CEO | Dr. Christopher J. Kirk Ph.D. |
Address | 4000 Shoreline Court, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
